ICAM1 and B-cell chronic lymphocytic leukemia: In chronic lymphocytic leukemia cells, ephrin-A4 activation by EphA2-Fc significantly reduced cell adhesion to fibronectin-, collagen-, laminin-, ICAM-1-, and VCAM-1-coated surfaces [10].